Yellow Wood Partners has acquired foot-care brand Dr. Scholl’s with plans to turn it into a broader wellness company.

The private equity firm has closed on the $585 million acquisition. Dr. Scholl’s was carved out of Bayer, and did $234 million in sales for 2018.

Yellow Wood is planning to build “the Scholl’s Wellness Company,” which will operate as a stand-alone wellness business. Craig Stevenson, who was previously with Clorox, has been appointed chief executive officer.

“The Dr. Scholl’s brand fits extremely well with the Yellow Wood consumer-focused business model where we bring our operational and financial resources to build a limited number of platform companies,” said Tad Yanagi, partner at Yellow Wood. “There is a significant opportunity to build the Scholl’s Wellness Company into a broader wellness business through both organic growth and additional acquisitions.”

Yellow Wood has a history of buy-and-build dealmaking. The firm backed PDC, the mass-market platform that owned brands including Dr Teal’s, before selling it to CVC Partners. Yellow Wood backs Freeman Beauty, another mass-market platform business that owns Freeman masks and Paris Presents.

For more from WWD.com, see:

To Scale, New York’s Chillhouse Plans New Business Model

Beauty Veteran David Olsen Joins Private Equity Ranks

Deciem Will Close for Black Friday, But Discount Products All Month Long

load comments
blog comments powered by Disqus